Cohera Medical, Inc. is a medical device company that is developing a revolutionary line of surgical adhesives and wound management products. Cohera’s lead product under development, TissuGlu®, is an easy-to-use, resorbable adhesive that positions tissues for optimal healing while minimizing fluid accumulation. The unique chemical design of Cohera’s products can be formulated for use in a wide variety of surgical applications including plastic surgery, general surgery and orthopedic surgery.
http://www.coheramedical.com/
http://www.coheramedical.com/
Location: United States, North Carolina, Raleigh
Total raised: $110M
Investors 2
| Date | Name | Website |
| - | Innovation... | innovation... |
| - | Kohlberg K... | kkr.com |
Funding Rounds 4
| Date | Series | Amount | Investors |
| 22.10.2015 | - | $50M | - |
| 19.12.2011 | Series C | $25M | - |
| 14.06.2010 | Series C | $25M | - |
| 25.01.2010 | Series C | $10M | - |
Mentions in press and media 18
| Date | Title | Description |
| 22.10.2015 | Daily funding roundup - October 22, 2015 | Numerify closed a $37.5M funding; Poynt raised $28M; Movement Ventures secured $5.5M Outlearn announced that it has raised $2 million in seed funding from General Catalyst Partners with participation from Paul Sagan, former CEO of Akamai Te... |
| 22.10.2015 | Cohera Medical, Inc.® Announces $50 Million in New Financing | PITTSBURGH--(BUSINESS WIRE)-- Cohera Medical, a leading innovator and developer of absorbable surgical adhesives and sealants, announced closing the first tranche of a $50 million equity financing led by KKR, a leading global investment f... |
| 22.10.2015 | Cohera Medical Raises $50M in Funding | Cohera Medical, a Pittsburgh, PA-based developer of absorbable surgical adhesives and sealants, closed the first tranche of a $50m equity financing. The round was led by KKR with participation from existing private investors. In conjunction... |
| 19.12.2014 | Cohera’s Sylys sealant wins quick review at FDA | The FDA awarded priority review status to Cohera Medical‘s surgical sealant Sylys because the product addresses a significant unmet medical need. Sylys is designed to prevent anastomotic leaks in patients undergoing gastrointestinal surgery... |
| 23.01.2014 | Cohera Medical touts $26M Series D funding | Cohera Medical closed its Series D financing round, bringing in $26.3 million which will be dedicated to securing FDA clearance for its TissuGlu surgical adhesive and CE Mark approval for the Sylys surgical sealant. TissuGlu is an internal ... |
| 29.06.2012 | Cohera tops $8M in Series D | Funding Roundup | Cohera Medical’s Series D tops $8M Pittsburgh-based Cohera Medical raised more than $8.4 million in its Series D round, the funds from which will go toward expanding commercialization of its lead TissuGlu surgical adhesive in markets in Eur... |
| 26.06.2012 | Tissue glue for tummy tucks, reconstructive surgery raises $8 million | Other large flap procedures where Daly sees opportunities for his adhesive include lymph node dissection in cancer patients, bowel procedures and reconstruction of sternal defect in open-heart surgery. Describing how the company fits into t... |
| 19.12.2011 | Cohera Medical Raises $25M in Series C Financing | Cohera Medical, a Pittsburgh, PA-based developer of absorbable surgical adhesives and sealants, has raised $25m in Series C financing. A total of $16.5m was raised through existing investors and over $9m through new investors. Kern Whelan C... |
| 16.11.2011 | Tummy-tuck tissue glue company Cohera Medical nearing series C close | Cohera in September received the CE Mark for its TissuGlu surgical adhesive and said it planned to commence sales in Germany shortly thereafter. The company expects to begin its first U.S. clinical trials early next year, with the hopes of ... |
| 14.06.2010 | Cohera Medical over halfway through $25 million funding round | By Brandon Glenn Cohera Medical Inc. has raised $12.7 million in investment funding, nudging past the halfway point to what it hopes will be a $25 million Series C round. The funding comes in the form of convertible notes and was raised fro... |
Show more